Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.450
-0.150 (-5.77%)
At close: Dec 30, 2024, 4:00 PM
2.420
-0.030 (-1.22%)
After-hours: Dec 30, 2024, 6:22 PM EST
Mangoceuticals Employees
Mangoceuticals had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$251,667
Profits / Employee
-$3,108,613
Market Cap
6.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ontrak | 104 |
| IM Cannabis | 95 |
| Check-Cap | 85 |
| Vincerx Pharma | 42 |
| Viracta Therapeutics | 40 |
| Predictive Oncology | 35 |
| Edesa Biotech | 16 |
| Adial Pharmaceuticals | 7 |
MGRX News
- 11 days ago - Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewsWire
- 2 months ago - MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - GlobeNewsWire
- 2 months ago - Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Newsfile Corp
- 2 months ago - Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga
- 2 months ago - MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN - GlobeNewsWire
- 3 months ago - MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions - GlobeNewsWire
- 3 months ago - MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment - GlobeNewsWire
- 4 months ago - MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 - GlobeNewsWire